Condition
Pelvic Venous Disorders
Total Trials
3
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
P 3 (1)
Trial Status
Unknown1
Recruiting1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT05076448CompletedPrimary
The Efficacy and Safety of Interventions on the Pelvic Veins in Pelvic Venous Disorders
NCT06584799Phase 3RecruitingPrimary
Venoactive Drug Treatment of Pelvic Venous Disorders
NCT05085938Unknown
Complications of Gonadal Veins Embolization
Showing all 3 trials